Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 54Neoplasms 47Colorectal Neoplasms 31Prostatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 24Lung Neoplasms 21Leukemia, Myeloid, Acute 19Recurrence 12Stomach Neoplasms 11Multiple Myeloma 11Melanoma 11Head and Neck Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Ovarian Neoplasms 9Uterine Cervical Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Myelodysplastic Syndromes 8Lymphoma, Non-Hodgkin 8Lymphoma 8Glioma 8Brain Neoplasms 8Motor Activity 7Esophageal Neoplasms 7Carcinoma, Renal Cell 7Carcinoma, Hepatocellular 7Leukemia 6Hodgkin Disease 6Colonic Neoplasms 6

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pyruvate Kinase Deficiency of Red Cells × 30 days × Clear all
NCT04902833 2026-05-19

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Massachusetts General Hospital

Completed
18 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Pyruvate Kinase Deficiency of Red Cells, Anemia, Hemolytic, Congenital, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡